Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.

In English

Författare

  • Robert Koivula
  • Alison Heggie
  • Anna Barnett
  • Henna Cederberg
  • Tue H Hansen
  • Anitra D Koopman
  • Martin Ridderstråle
  • Femke Rutters
  • Henrik Vestergaard
  • Ramneek Gupta
  • Sanna Herrgård
  • Martijn W Heymans
  • Mandy H Perry
  • Simone Rauh
  • Maritta Siloaho
  • Harriet J A Teare
  • Barbara Thorand
  • Jimmy Bell
  • Søren Brunak
  • Gary Frost
  • Bernd Jablonka
  • Andrea Mari
  • Tim J McDonald
  • Jacqueline M Dekker
  • Torben Hansen
  • Andrew Hattersley
  • Markku Laakso
  • Oluf Pedersen
  • Veikko Koivisto
  • Hartmut Ruetten
  • Mark Walker
  • Ewan Pearson
  • Paul Franks
Visa allt

Summary, in English

The DIRECT (Diabetes Research on Patient Stratification) Study is part of a European Union Framework 7 Innovative Medicines Initiative project, a joint undertaking between four industry and 21 academic partners throughout Europe. The Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into clearly definable disease subclasses that can be treated more effectively than without stratification. This paper describes two new prospective cohort studies conducted as part of DIRECT.

Publiceringsår

2014

Språk

Engelska

Sidor

1132-1142

Publikation/Tidskrift/Serie

Diabetologia

Volym

57

Issue

6

Dokumenttyp

Artikel i tidskrift

Förlag

Springer

Ämne

  • Endocrinology and Diabetes

Status

Published

Forskningsgrupp

  • Genetic and Molecular Epidemiology
  • Diabetes - Clinical Obesity

ISBN/ISSN/Övrigt

  • ISSN: 1432-0428